Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiovascular Diseases | 5 | 2023 | 835 | 1.710 |
Why?
|
| Atherosclerosis | 8 | 2025 | 153 | 1.660 |
Why?
|
| Oxidative Stress | 7 | 2020 | 298 | 1.620 |
Why?
|
| Aryldialkylphosphatase | 4 | 2015 | 19 | 1.360 |
Why?
|
| Lipoproteins, LDL | 3 | 2025 | 46 | 1.310 |
Why?
|
| Anemia, Sickle Cell | 1 | 2024 | 64 | 0.840 |
Why?
|
| Machine Learning | 1 | 2025 | 177 | 0.830 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2023 | 38 | 0.810 |
Why?
|
| Proprotein Convertase 9 | 2 | 2022 | 13 | 0.740 |
Why?
|
| Interleukin-6 | 2 | 2014 | 321 | 0.740 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2022 | 33 | 0.740 |
Why?
|
| Inflammation | 5 | 2022 | 1147 | 0.700 |
Why?
|
| Calcinosis | 1 | 2020 | 85 | 0.630 |
Why?
|
| Polyphenols | 1 | 2020 | 59 | 0.610 |
Why?
|
| Triglycerides | 2 | 2012 | 244 | 0.600 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 94 | 0.590 |
Why?
|
| Aortic Valve | 1 | 2020 | 190 | 0.580 |
Why?
|
| Berberine | 1 | 2018 | 4 | 0.560 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 28 | 0.560 |
Why?
|
| Microbiota | 1 | 2020 | 129 | 0.560 |
Why?
|
| Polyesters | 1 | 2018 | 47 | 0.550 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 189 | 0.540 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2014 | 23 | 0.540 |
Why?
|
| Endometriosis | 2 | 2014 | 28 | 0.540 |
Why?
|
| Lipoprotein(a) | 1 | 2017 | 8 | 0.530 |
Why?
|
| Infertility, Female | 2 | 2014 | 46 | 0.530 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 167 | 0.510 |
Why?
|
| Ovulation Induction | 2 | 2014 | 13 | 0.500 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 236 | 0.480 |
Why?
|
| Blood Platelets | 2 | 2022 | 102 | 0.470 |
Why?
|
| Enzyme Assays | 1 | 2015 | 15 | 0.460 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 58 | 0.440 |
Why?
|
| Pregnancy Outcome | 2 | 2014 | 194 | 0.440 |
Why?
|
| Macrophages | 1 | 2020 | 1039 | 0.430 |
Why?
|
| Lipid Peroxidation | 4 | 2012 | 65 | 0.420 |
Why?
|
| Estradiol | 2 | 2012 | 257 | 0.410 |
Why?
|
| Apolipoproteins A | 1 | 2012 | 1 | 0.390 |
Why?
|
| Biomarkers | 3 | 2014 | 1408 | 0.390 |
Why?
|
| Stroke | 2 | 2024 | 1196 | 0.390 |
Why?
|
| Humans | 23 | 2025 | 63443 | 0.370 |
Why?
|
| Nanoparticles | 1 | 2018 | 513 | 0.370 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 615 | 0.360 |
Why?
|
| Risk Factors | 6 | 2024 | 5353 | 0.350 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 491 | 0.320 |
Why?
|
| Premenopause | 1 | 2010 | 60 | 0.320 |
Why?
|
| Physical Fitness | 1 | 2010 | 92 | 0.310 |
Why?
|
| Dietary Supplements | 2 | 2023 | 235 | 0.310 |
Why?
|
| Linoleic Acid | 2 | 2009 | 19 | 0.300 |
Why?
|
| Myocardial Ischemia | 1 | 2010 | 117 | 0.300 |
Why?
|
| Colorimetry | 1 | 2008 | 25 | 0.290 |
Why?
|
| Apolipoprotein C-III | 1 | 2008 | 5 | 0.290 |
Why?
|
| Apolipoproteins | 1 | 2008 | 14 | 0.280 |
Why?
|
| Animals | 10 | 2023 | 20663 | 0.270 |
Why?
|
| Reactive Oxygen Species | 1 | 2008 | 224 | 0.270 |
Why?
|
| Motor Activity | 1 | 2010 | 346 | 0.260 |
Why?
|
| Diet | 3 | 2020 | 527 | 0.250 |
Why?
|
| Adult | 7 | 2024 | 16823 | 0.230 |
Why?
|
| Hypertension | 2 | 2022 | 586 | 0.220 |
Why?
|
| Female | 9 | 2024 | 32878 | 0.220 |
Why?
|
| Antioxidants | 4 | 2010 | 252 | 0.220 |
Why?
|
| Prospective Studies | 3 | 2024 | 3293 | 0.210 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2023 | 16 | 0.210 |
Why?
|
| Magnesium | 1 | 2024 | 54 | 0.210 |
Why?
|
| Docosahexaenoic Acids | 1 | 2023 | 31 | 0.210 |
Why?
|
| Cognition | 2 | 2023 | 484 | 0.190 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 220 | 0.180 |
Why?
|
| Serotonin | 1 | 2022 | 60 | 0.180 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 1617 | 0.180 |
Why?
|
| Glutathione Peroxidase | 2 | 2012 | 28 | 0.180 |
Why?
|
| White Matter | 1 | 2022 | 123 | 0.170 |
Why?
|
| Apolipoprotein A-V | 2 | 2012 | 2 | 0.170 |
Why?
|
| Male | 7 | 2024 | 29889 | 0.170 |
Why?
|
| Insulin Resistance | 1 | 2024 | 412 | 0.170 |
Why?
|
| Biophysics | 1 | 2020 | 42 | 0.170 |
Why?
|
| Acute Coronary Syndrome | 1 | 2023 | 253 | 0.160 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 54 | 0.160 |
Why?
|
| Superoxide Dismutase | 2 | 2012 | 225 | 0.160 |
Why?
|
| Fatty Acids | 2 | 2012 | 200 | 0.150 |
Why?
|
| Middle Aged | 5 | 2024 | 17612 | 0.150 |
Why?
|
| Aldehydes | 2 | 2009 | 16 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 697 | 0.150 |
Why?
|
| C-Reactive Protein | 2 | 2010 | 166 | 0.140 |
Why?
|
| Cell Membrane | 1 | 2020 | 496 | 0.140 |
Why?
|
| Lipoproteins | 2 | 2010 | 84 | 0.130 |
Why?
|
| Risk Assessment | 1 | 2024 | 2079 | 0.130 |
Why?
|
| Platelet Aggregation | 2 | 2022 | 24 | 0.130 |
Why?
|
| Pregnancy | 2 | 2014 | 2334 | 0.120 |
Why?
|
| Cholesterol | 2 | 2008 | 259 | 0.120 |
Why?
|
| Hemolysis | 1 | 2015 | 40 | 0.120 |
Why?
|
| Gonadotropins | 1 | 2014 | 14 | 0.110 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 215 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 325 | 0.110 |
Why?
|
| Mice | 5 | 2020 | 10844 | 0.110 |
Why?
|
| Aspirin | 2 | 2022 | 171 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 454 | 0.110 |
Why?
|
| Sex Factors | 2 | 2023 | 978 | 0.110 |
Why?
|
| Diabetes Mellitus | 2 | 2024 | 540 | 0.110 |
Why?
|
| Oxidation-Reduction | 3 | 2010 | 326 | 0.100 |
Why?
|
| Dinoprost | 1 | 2012 | 19 | 0.100 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2012 | 32 | 0.100 |
Why?
|
| Pregnancy Rate | 1 | 2012 | 31 | 0.100 |
Why?
|
| Fertilization in Vitro | 1 | 2012 | 85 | 0.090 |
Why?
|
| Carboxylic Acids | 2 | 2009 | 9 | 0.090 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 142 | 0.090 |
Why?
|
| Anticoagulants | 1 | 2015 | 495 | 0.090 |
Why?
|
| PPAR alpha | 2 | 2008 | 34 | 0.080 |
Why?
|
| Lipids | 2 | 2010 | 315 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1654 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2017 | 687 | 0.080 |
Why?
|
| Malondialdehyde | 1 | 2010 | 15 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2020 | 3035 | 0.080 |
Why?
|
| Dicarboxylic Acids | 1 | 2009 | 2 | 0.080 |
Why?
|
| Lipid Peroxides | 1 | 2009 | 11 | 0.080 |
Why?
|
| alpha-Tocopherol | 1 | 2009 | 18 | 0.080 |
Why?
|
| India | 1 | 2010 | 159 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1094 | 0.080 |
Why?
|
| Oxygen Consumption | 1 | 2010 | 209 | 0.080 |
Why?
|
| Linear Models | 1 | 2010 | 409 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 719 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2010 | 250 | 0.070 |
Why?
|
| Apolipoprotein A-I | 1 | 2008 | 23 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2008 | 78 | 0.070 |
Why?
|
| Exercise Test | 1 | 2010 | 252 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 131 | 0.070 |
Why?
|
| Peroxidase | 1 | 2008 | 71 | 0.070 |
Why?
|
| Calcium | 1 | 2010 | 575 | 0.060 |
Why?
|
| Oxygen | 1 | 2008 | 317 | 0.060 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 32 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 455 | 0.060 |
Why?
|
| Aged | 3 | 2024 | 14446 | 0.060 |
Why?
|
| Physical Conditioning, Animal | 1 | 2005 | 43 | 0.060 |
Why?
|
| Obesity | 1 | 2012 | 1235 | 0.050 |
Why?
|
| Puerto Rico | 1 | 2024 | 135 | 0.050 |
Why?
|
| Disease Progression | 1 | 2008 | 1172 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2008 | 3396 | 0.050 |
Why?
|
| Metformin | 1 | 2024 | 74 | 0.050 |
Why?
|
| Platelet Function Tests | 1 | 2022 | 11 | 0.050 |
Why?
|
| Adenosine Diphosphate | 1 | 2022 | 42 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 2187 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2022 | 225 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2022 | 226 | 0.040 |
Why?
|
| Young Adult | 1 | 2010 | 4694 | 0.040 |
Why?
|
| Adolescent | 1 | 2010 | 6245 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 5462 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 1256 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2024 | 2570 | 0.030 |
Why?
|
| Receptors, LDL | 2 | 2009 | 34 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 2575 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 721 | 0.030 |
Why?
|
| Oxidants | 1 | 2010 | 18 | 0.020 |
Why?
|
| Linoleic Acids | 1 | 2009 | 8 | 0.020 |
Why?
|
| Pyruvic Acid | 1 | 2009 | 13 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 1 | 2009 | 18 | 0.020 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2009 | 26 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2009 | 131 | 0.020 |
Why?
|
| Salicylates | 1 | 2008 | 9 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2008 | 15 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 301 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2008 | 218 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2008 | 400 | 0.010 |
Why?
|
| CD36 Antigens | 1 | 2005 | 26 | 0.010 |
Why?
|
| PPAR gamma | 1 | 2005 | 76 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 2109 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 1980 | 0.010 |
Why?
|
| Biological Transport | 1 | 2005 | 291 | 0.010 |
Why?
|
| Proteins | 1 | 2010 | 750 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 1469 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 1180 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 921 | 0.010 |
Why?
|